Literature DB >> 233157

Changes in lymphocyte beta-adrenergic receptors in depression and mania.

I Extein, J Tallman, C C Smith, F K Goodwin.   

Abstract

The beta-adrenergic receptors were studied in vitro in lymphocytes obtained from patients with major affective disorders and controls. Specific L-[3H]-dihydroalprenolol binding was decreased in both depressed and manic patients compared to controls and euthymic patients. Isoproterenol-stimulated, but not prostaglandin El-stimulated, cyclic adenosine-3',5'-monophosphate production was decreased in manic and depressed patients. These results suggest decreased lymphocyte beta-receptor functioning in depression and mania. This decrease may be an index of changes in brain beta-receptors in mania and depression, or may simply reflect homeostatic regulation of peripheral beta-receptors in response to stress-induced increases in circulating catecholamines.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 233157     DOI: 10.1016/0165-1781(79)90061-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

Review 1.  Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.

Authors:  H Wachtel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  Therapeutic concentrations of lithium and carbamazepine inhibit cGMP accumulation in human lymphocytes. A clinical model for a possible common mechanism of action?

Authors:  T Schubert; L Stoll; W E Müller
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells.

Authors:  H W Moises; B Bering; W E Müller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

4.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

6.  Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

Authors:  B Lerer; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Lymphocyte beta-adrenergic receptor binding in panic disorder.

Authors:  S L Brown; D S Charney; S W Woods; G R Heninger; J Tallman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Genetic association of cyclic AMP signaling genes with bipolar disorder.

Authors:  M L McDonald; C MacMullen; D J Liu; S M Leal; R L Davis
Journal:  Transl Psychiatry       Date:  2012-10-02       Impact factor: 6.222

9.  Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A.

Authors:  Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

Review 10.  Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.

Authors:  Fuencisla Pilar-Cuéllar; Rebeca Vidal; Alvaro Díaz; Elena Castro; Severiano dos Anjos; Jesús Pascual-Brazo; Raquel Linge; Veronica Vargas; Helena Blanco; Beatriz Martínez-Villayandre; Ángel Pazos; Elsa M Valdizán
Journal:  Neural Plast       Date:  2013-06-19       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.